[HTML][HTML] Eculizumab in atypical hemolytic uremic syndrome: strategies toward restrictive use
KL Wijnsma, C Duineveld, JFM Wetzels… - Pediatric …, 2019 - Springer
With the introduction of the complement C5-inhibitor eculizumab, a new era was entered for
patients with atypical hemolytic uremic syndrome (aHUS). Eculizumab therapy very …
patients with atypical hemolytic uremic syndrome (aHUS). Eculizumab therapy very …
Eculizumab in atypical hemolytic uremic syndrome: strategies toward restrictive use.
KL Wijnsma, C Duineveld, JFM Wetzels… - Pediatric …, 2019 - go.gale.com
With the introduction of the complement C5-inhibitor eculizumab, a new era was entered for
patients with atypical hemolytic uremic syndrome (aHUS). Eculizumab therapy very …
patients with atypical hemolytic uremic syndrome (aHUS). Eculizumab therapy very …
Eculizumab in atypical hemolytic uremic syndrome: strategies toward restrictive use.
KL Wijnsma, C Duineveld, JFM Wetzels… - Pediatric …, 2019 - search.ebscohost.com
With the introduction of the complement C5-inhibitor eculizumab, a new era was entered for
patients with atypical hemolytic uremic syndrome (aHUS). Eculizumab therapy very …
patients with atypical hemolytic uremic syndrome (aHUS). Eculizumab therapy very …
Correction to: Eculizumab in atypical hemolytic uremic syndrome: strategies toward restrictive use
KL Wijnsma, C Duineveld, JFM Wetzels… - 2019 - core.ac.uk
International License (http://creativecommons. org/licenses/by/4.0/), which permits
unrestricted use, distribution, and reproduction in any medium, provided you give …
unrestricted use, distribution, and reproduction in any medium, provided you give …
Correction to: Eculizumab in atypical hemolytic uremic syndrome: strategies toward restrictive use
KL Wijnsma, C Duineveld, JFM Wetzels… - Pediatric …, 2019 - Springer
Correction to: Eculizumab in atypical hemolytic uremic syndrome: strategies toward restrictive
use | Pediatric Nephrology Skip to main content SpringerLink Account Menu Find a journal …
use | Pediatric Nephrology Skip to main content SpringerLink Account Menu Find a journal …
Eculizumab in atypical hemolytic uremic syndrome: strategies toward restrictive use
KL Wijnsma, C Duineveld, JFM Wetzels, NC van de Kar - 2019 - repository.ubn.ru.nl
Eculizumab in atypical hemolytic uremic syndrome: strategies toward restrictive use Page 1
REVIEW Eculizumab in atypical hemolytic uremic syndrome: strategies toward restrictive use …
REVIEW Eculizumab in atypical hemolytic uremic syndrome: strategies toward restrictive use …
Eculizumab in atypical hemolytic uremic syndrome: strategies toward restrictive use.
KL Wijnsma, C Duineveld, JFM Wetzels… - Pediatric Nephrology …, 2018 - europepmc.org
With the introduction of the complement C5-inhibitor eculizumab, a new era was entered for
patients with atypical hemolytic uremic syndrome (aHUS). Eculizumab therapy very …
patients with atypical hemolytic uremic syndrome (aHUS). Eculizumab therapy very …
Correction to: Eculizumab in atypical hemolytic uremic syndrome: strategies toward restrictive use
KL Wijnsma, C Duineveld… - Pediatric …, 2019 - pubmed.ncbi.nlm.nih.gov
Correction to: Eculizumab in atypical hemolytic uremic syndrome: strategies toward restrictive
use Correction to: Eculizumab in atypical hemolytic uremic syndrome: strategies toward …
use Correction to: Eculizumab in atypical hemolytic uremic syndrome: strategies toward …
[PDF][PDF] Eculizumab in atypical hemolytic uremic syndrome: strategies toward restrictive use
KL Wijnsma, C Duineveld, JFM Wetzels… - 2018 - d-nb.info
With the introduction of the complement C5-inhibitor eculizumab, a new era was entered for
patients with atypical hemolytic uremic syndrome (aHUS). Eculizumab therapy very …
patients with atypical hemolytic uremic syndrome (aHUS). Eculizumab therapy very …
[HTML][HTML] Eculizumab in atypical hemolytic uremic syndrome: strategies toward restrictive use
KL Wijnsma, C Duineveld, JFM Wetzels… - Pediatric Nephrology …, 2019 - ncbi.nlm.nih.gov
With the introduction of the complement C5-inhibitor eculizumab, a new era was entered for
patients with atypical hemolytic uremic syndrome (aHUS). Eculizumab therapy very …
patients with atypical hemolytic uremic syndrome (aHUS). Eculizumab therapy very …